A Novel Berberine - Metformin Hybrid Compound Exerts Therapeutic Effects on Obese Type 2 Diabetic Rats.
In conclusion, our results suggest that the newly synthesized BMH473 is beneficial for maintaining glucose and lipid homeostasis in type 2 diabetic rats, and exhibits better anti - hyperlipidemic effects compared to metformin and berberine. This article is protected by copyright. All rights reserved.
PMID: 30883863 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Pharmacology and Physiology - Category: Drugs & Pharmacology Authors: Jia D, Li ZW, Zhou X, Gao Y, Feng Y, Ma M, Wu Z, Li W Tags: Clin Exp Pharmacol Physiol Source Type: research
More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Fortamet | Genetics | Liver | Metformin | Obesity | Physiology | Study | Urology & Nephrology